Abstract
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have